1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX
Mid-range Performer
Download real time
140.09 2.57 (1.87%)
66.32% Gain from 52W Low
977.2K
XNAS Volume

XNAS 17 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Neurocrine Biosciences, Inc. is on 30 Oct 2025 for the purpose of Neurocrine Biosciences Inc Third Quarter Earnings Results for 2025 See details

Neurocrine Biosciences, Inc. quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents